Stay updated with breaking news from C Diff Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a total of 26 ibezapolstat-treated patients in Phases 2a and 2b, the Clinical Cure rate is 96% Meets protocol primary objective of assessing the primary...
TEMECULA, Calif., Jan. 27, 2023 (SEND2PRESS NEWSWIRE) — Neotrope®, a 40 year old marketing and entertainment company, announced today that it is now accepting applications from U.S. based 501(c)(3) charities
C Diff Foundation News Room and Media Kit 2022 - Pressroom and Press Releases from C Diff Foundation at Send2Press Newswire
ENewsChannels NEWS: -- C Diff Foundation announced today that the 9th Annual International C. diff. Conference and Health EXPO is honored to welcome over 40 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, and academia. World-renowned presenters will deliver data and discuss critical information on a leading Healthcare-Associated Infection (HAI), Clostridioides difficile with global healthcare-associated issues on Nov. 4 - 5, 2021. :: News from eNewsChannels
/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...